Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
2.090
-0.090 (-4.13%)
At close: Jan 21, 2025, 4:00 PM
2.157
+0.067 (3.19%)
After-hours: Jan 21, 2025, 6:00 PM EST
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $9.07 million as of January 22, 2025. Its market cap has increased by 286.82% in one year.
Market Cap
9.07M
Enterprise Value
2.30M
1-Year Change
286.82%
Ranking
Category
Stock Price
$2.09
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $9.07M, a decrease of -95.62%. That is a compound annual growth rate of -71.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 9.47M | -3.11% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |